TD-106

Modify Date: 2024-01-22 23:08:02

TD-106 Structure
TD-106 structure
Common Name TD-106
CAS Number 2250288-69-6 Molecular Weight 273.25
Density N/A Boiling Point N/A
Molecular Formula C12H11N5O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of TD-106


TD-106 is a cereblon (CRBN) modulator, which can be used for targeted protein degradation. BRD4 PROTACs with TD-106 induce BRD4 degradation[1].

 Names

Name TD-106

 TD-106 Biological Activity

Description TD-106 is a cereblon (CRBN) modulator, which can be used for targeted protein degradation. BRD4 PROTACs with TD-106 induce BRD4 degradation[1].
Related Catalog
Target

CRBN[1]

In Vitro TD-106 (0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM, 10 μM, and 100 μM; 72 hours) inhibits the proliferation of NCI-H929 myeloma cell line with an CC50 of 0.039 μM[1]. TD-106 (1, 10, 100, and 1000 nM) induces the degradation of IKZF1/3 in NCI-H929 cells[1]. Cell Cytotoxicity Assay[1] Cell Line: NCI-H929 cells Concentration: 72 hours Incubation Time: 0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM, 10 μM, and 100 μM Result: Inhibited cell proliferation with an CC50 of 0.039 μM.
In Vivo TD-106 (50 mg/kg; intraperitoneally; q.d. for 14 days) possesses anti-myeloma activity in SCID mice with TMD-8 xenograft model. Animal Model: Female SCID (CB-17/IcrCri-scid) mice with TMD-8 xenograft model[1] Dosage: 50 mg/kg Administration: Intraperitoneally (i.p.); q.d. for 14 days Result: Treatment inhibited tumor growth during this duration.
References

[1]. Kim SA, et al. A novel cereblon modulator for targeted protein degradation. Eur J Med Chem. 2019 Mar 15;166:65-74.

 Chemical & Physical Properties

Molecular Formula C12H11N5O3
Molecular Weight 273.25
Storage condition 2-8℃